Earnings Feed
Start Free
Home/Filings/4/0001140361-13-000815
4//SEC Filing

HOLMES E CARMACK 4

Accession 0001140361-13-000815

CIK 0001095981other
View on SEC.govCompany Profile

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 5:40 PM ET

Size

8.5 KB

Accession

0001140361-13-000815

Insider Transaction Report

Form 4
Period: 2013-01-01
CYTORI THERAPEUTICS, INC.CYTX
HOLMES E CARMACK
Director
Transactions
  • Award

    Restricted Stock Award (Common Stock)

    2013-01-01+6,100→ 6,100 total
  • Award

    Non-Qualified Stock Option (Right to Buy)

    2013-01-01+6,100→ 251,100 total
    Exercise: $2.80From: 2013-02-01Exp: 2023-01-01→ Common Stock (6,100 underlying)
Holdings

  • Common Stock

    (indirect: By Trust)
    27,401

  • Common Stock

    10,000
Footnotes (3)
  • [F1]The Restricted Stock Award vests in full on January 1, 2014, subject to the terms of the Company's 2004 Equity Incentive Plan.
  • [F2]These shares are held of record by E. Carmack Holmes & Carolyn K Holmes TTEE, Holmes Living Trust DD 05/15/92.
  • [F3]The stock options vest 1/24th per month from date of grant, subject to the terms of the Company's 2004 Equity Incentive Plan.

Documents

1 file

Issuer

CYTORI THERAPEUTICS, INC.

CIK 0001095981

→
Entity typeother

Related Parties

1
  • filerCIK 0001259720

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:40 PM ET
Size
8.5 KB
View on SEC.gov